Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-1-16
pubmed:abstractText
Thrombotic thrombocytopenic purpura (TTP) in adults is usually caused by autoantibody inhibitors of ADAMTS13. Treatment with plasma exchange is often effective but does not address the underlying autoimmune process.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1539-3704
pubmed:author
pubmed:issnType
Electronic
pubmed:day
21
pubmed:volume
138
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
105-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12529092-ADAM Proteins, pubmed-meshheading:12529092-Adult, pubmed-meshheading:12529092-Antibodies, Monoclonal, pubmed-meshheading:12529092-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:12529092-Autoantibodies, pubmed-meshheading:12529092-Chronic Disease, pubmed-meshheading:12529092-Cyclophosphamide, pubmed-meshheading:12529092-Drug Therapy, Combination, pubmed-meshheading:12529092-Female, pubmed-meshheading:12529092-Humans, pubmed-meshheading:12529092-Immunosuppressive Agents, pubmed-meshheading:12529092-Metalloendopeptidases, pubmed-meshheading:12529092-Platelet Count, pubmed-meshheading:12529092-Purpura, Thrombotic Thrombocytopenic, pubmed-meshheading:12529092-Recurrence, pubmed-meshheading:12529092-Remission Induction, pubmed-meshheading:12529092-von Willebrand Factor
pubmed:year
2003
pubmed:articleTitle
Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
pubmed:affiliation
Washington University School of Medicine, 660 South Euclid Avenue, Box 8022, St. Louis, Missouri 63110, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports, Research Support, Non-U.S. Gov't